The shareholders of Kofola a.s., the leading central European producer of non-alcoholic beverages, have acquired the majority share in the company Green-Swan Pharmaceuticals CR, a.s., one of the most significant Czech producers and distributors of nutritional supplements.
The transaction is of an investment nature with the purpose of exploiting the mutual synergies of Kofola and Green-Swan Pharmaceuticals in several areas, such as marketing, purchasing, development and research.
Both companies will continue to implement their business and marketing strategies. In addition, the companies are also preparing joint business projects.
About Kofola, a.s.
Kofola, a.s. is one of the most significant producers of non-alcoholic beverages in Central Europe. With over 1,1000 employees, the company operates in the Visegrad Four countries, i.e. the Czech Republic, Slovakia, Poland and Hungary, and also exports its products to countries further afield. Its product portfolio includes Kofola – a traditional, original-recipe cola beverage, a range of fruit drinks, Jupí syrups and concentrates, Jupík children's beverage, Rajec natural spring water, Top Topic grape beverage, the real American RC Cola, and the Capri Sonne, Chito Tonic, Snipp and Sentino brands. More information about the company can be found at www.kofola.cz.
About Green-Swan Pharmaceuticals CR , a.s.
Green-Swan Pharmaceuticals CR, a.s. was established in 1998 with a contribution of investment capital from Great Britain. Under the leadership of young Czech managers, primarily doctors and pharmacists, the company has become one of the Czech Republic's largest companies engaged in the production and distribution of nutritional supplements. More information about the company is available at www.grswan.cz